Xianwen W. Yuan

321, Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease

Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: April 07, 2024

Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B

Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: September 18, 2023

Hepatitis B virus related liver cirrhosis complicated with necrotizing myopathy: a case report

Hepatitis B virus related liver cirrhosis complicated with necrotizing myopathy: a case report

Journal: Zhonghua nei ke za zhi

Published: June 28, 2022

Alleviation of Hepatic Steatosis by 4-azidophlorizin via the Degradation of Geranylgeranyl Diphosphate Synthase by the Ubiquitin-Proteasome Pathway in Vivo and in Vitro.

Alleviation of Hepatic Steatosis by 4-azidophlorizin via the Degradation of Geranylgeranyl Diphosphate Synthase by the Ubiquitin-Proteasome Pathway in Vivo and in Vitro.

Journal: Advanced biology

Published: May 29, 2022

Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease

Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: April 24, 2022

Study on plasma Golgi protein 73 and related models in the diagnosis of nonalcoholic fatty liver disease

Study on plasma Golgi protein 73 and related models in the diagnosis of nonalcoholic fatty liver disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: January 20, 2022

Serum proteome profiling reveals differentially expressed proteins between subjects with metabolically healthy obesity and nonalcoholic fatty liver disease.

Serum proteome profiling reveals differentially expressed proteins between subjects with metabolically healthy obesity and nonalcoholic fatty liver disease.

Journal: Journal of proteomics

Published: December 25, 2021

Study on heme oxygenase-1 and HAP model for the diagnosis of chronic hepatitis B-related liver fibrosis

Study on heme oxygenase-1 and HAP model for the diagnosis of chronic hepatitis B-related liver fibrosis

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: September 13, 2021

Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis

Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: June 16, 2020

Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease.

Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease.

Journal: Journal of proteomics

Published: December 18, 2019

WIPI2 depletion inhibits the growth of hepatocellular carcinoma cells through the AMPK signaling pathway.

WIPI2 depletion inhibits the growth of hepatocellular carcinoma cells through the AMPK signaling pathway.

Journal: Oncology reports

Published: November 04, 2019

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis.

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis.

Journal: Cancer cell international

Published: September 04, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026